Integrity Applications said today it inked an exclusive distribution deal with MediReva B.V. to distribute its GlucoTrack non-invasive glucose measuring device in the Netherlands, effective December 22.
Integrity Application’s flagship GlucoTrack is a sensor that clips to the earlobe and uses a combination of metrics to determine blood glucose based on physiological changes in the body.
“This distribution agreement in the Netherlands is a major milestone on our path to commercializing GlucoTrack. It represents an important first program in our updated commercial partnering strategy. We are excited to work with MediReva to launch GlucoTrack in the Netherlands, and we look forward to continuing our efforts in making the device available for patients in markets around the world,” chief commercial officer David Podwalski said in a press release.
MediReva is a family owned business that covers the entirety of the Netherlands alongside limited coverage in Belgium and Luxembourg, according to Wilmington, Del.-based Integrity Applications.
As part of the agreement, MediReva will commit substantial resources including dedicated sales and customer support staff for the GlucoTrack, Integrity Applications said.
“MediReva is one of the leading home care support companies in the Netherlands. We have years of experience in helping patients manage their diabetes and we are excited about bringing GlucoTrack to the marketplace,” MediReva CEO Paul Ummels said in a prepared statement.
